BACKGROUND Burden of adverse drug reactions (ADRs), in home-environment and domestic settings, is unknown. OBJECTIVE To discuss the epidemiology of reported ADRs to 13-Aban drug and poison information center (DPIC) and to discuss the burden of hospitalization caused by these ADRs from commonly implicated therapeutic groups. METHODS A retrospective analysis of the yellow card schemes of susp...

BACKGROUND Cough is listed as an adverse drug reaction (ADR) on the labels of angiotensin receptor blockers (ARB). However, a causal association with cough has also been reported for angiotensin converting enzyme inhibitors (ACEI), which have frequently been used as comparator drugs in the registration clinical trials of ARBs. This prompted us to examine the possible influence of using comparat...

BACKGROUND With the incidence of adverse drug events (ADEs) and adverse drug reactions (ADRs) higher in the intensive care unit (ICU) than other areas of the hospital, it is suspected that ADE/ADR surveillance systems differ between ICU and non-ICU areas. However, there is a lack of information about ADE/ADR identification, reporting, and evaluation strategies in the ICU. Understanding the freq...

ABSTRACT Objectives: The drugs commonly used/prescribed by dentists/physicians or consumed patients may cause adverse drug reactions (ADRs). Therefore, the possibility of dentists to encounter an ADR during their professional lives cannot be underestimated and contribution pharmacovigilance systems notifying spontaneous reports play important role in early detection prevention ADRs. This study ...

The pandemic of Coronavirus Disease 2019 (COVID-19) has now affected the entire globe which was first surfaced in China December 2019. In absence effective therapy to manage COVID-19, repurposed therapies were being used condition. view an urgent need for definitive therapy, multiple drugs, and investigational drug candidates are tried clinical trials may lead emergence unknown short term long ...

Globally, adverse drug reactions (ADRs), one of the leading causes of morbidity and mortality, will continue to pose a threat to public health as long as drugs are being used to treat various ailments. Prompt ADR reporting is crucial in ensuring drug safety. The aim of this narrative review was to highlight the role of pharmacists in pharmacovigilance and to identify barriers and facilitators t...

BackgroundPharmacovigilance is a critical component to facilitate clinicians’ decision-making alter or discontinue therapy. However, self-administration of oral targeted therapy (OTT) requires fewer clinical visits than parenteral infusions, potentially leading an increase in the under-reporting adverse drug reactions (ADRs).Objective(s)To identify factors associated with patients reporting ADR...

background and objectives: pharmacovigilance is central to the control of the menace of adverse drugs reactions. despite the fact that development of policy and practice framework to improve patients’ safety partly rely on availability of authentic data on pharmacovigilance activities, knowledge about pharmacovigilance activities among healthcare professionals in nigeria is limited. to help fil...

For the safe use of medicinal products, it is important that physicians publish adverse experiences with a medicinal product-particularly regarding side effects-in the scientific literature. However, when searching applicable publications, we determined that adverse drug reactions (ADRs) are often published several months after their occurrence. In the context of patient safety, this is rather ...

Harms of drugs are an important cause of mortality and morbidity. The use of pharmaceuticals always entails a risk of adverse events, often to an unknown extent, and increased drug utilization has made drug-related problems a common occurrence (1). It is, for instance, estimated that adverse drug reactions (ADRs) cause the European Union almost 200,000 deaths annually (2) and cost approximately...